Significance of Micrometastases: Circulating Tumor Cells and Disseminated Tumor Cells in Early Breast Cancer

Por Oakman, Catherine, Pestrin, Marta, Bessi, Silvia, Galardi, Francesca, Di Leo, Angelo
Publicado em 2010

Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer

Por Oakman, Catherine, Bessi, Silvia, Zafarana, Elena, Galardi, Francesca, Biganzoli, Laura, Di Leo, Angelo
Publicado em 2009

Can Biomarker Assessment on Circulating Tumor Cells Help Direct Therapy in Metastatic Breast Cancer?

Por Turner, Natalie, Pestrin, Marta, Galardi, Francesca, De Luca, Francesca, Malorni, Luca, Di Leo, Angelo
Publicado em 2014

Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients

Por Pestrin, Marta, Salvianti, Francesca, Galardi, Francesca, De Luca, Francesca, Turner, Natalie, Malorni, Luca, Pazzagli, Mario, Di Leo, Angelo, Pinzani, Pamela
Publicado no Mol Oncol (2014)

Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing

Por Salvianti, Francesca, Rotunno, Giada, Galardi, Francesca, De Luca, Francesca, Pestrin, Marta, Vannucchi, Alessandro Maria, Di Leo, Angelo, Pazzagli, Mario, Pinzani, Pamela
Publicado no Biomol Detect Quantif (2015)

Cell-Free DNA-Methylation-Based Methods and Applications in Oncology

Por Galardi, Francesca, De Luca, Francesca, Romagnoli, Dario, Biagioni, Chiara, Moretti, Erica, Biganzoli, Laura, Di Leo, Angelo, Migliaccio, Ilenia, Malorni, Luca, Benelli, Matteo
Publicado no Biomolecules (2020)

Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer

Por De Luca, Francesca, Rotunno, Giada, Salvianti, Francesca, Galardi, Francesca, Pestrin, Marta, Gabellini, Stefano, Simi, Lisa, Mancini, Irene, Vannucchi, Alessandro Maria, Pazzagli, Mario, Di Leo, Angelo, Pinzani, Pamela
Publicado no Oncotarget (2016)

Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy

Por Bonechi, Martina, Galardi, Francesca, Biagioni, Chiara, De Luca, Francesca, Bergqvist, Mattias, Neumüller, Magnus, Guarducci, Cristina, Boccalini, Giulia, Gabellini, Stefano, Migliaccio, Ilenia, Di Leo, Angelo, Pestrin, Marta, Malorni, Luca
Publicado no Oncotarget (2018)

Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice

Por McCartney, Amelia, Migliaccio, Ilenia, Bonechi, Martina, Biagioni, Chiara, Romagnoli, Dario, De Luca, Francesca, Galardi, Francesca, Risi, Emanuela, De Santo, Irene, Benelli, Matteo, Malorni, Luca, Di Leo, Angelo
Publicado no Front Oncol (2019)

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structur...

Por Nanni, Oriana, Viale, Pierluigi, Vertogen, Bernadette, Lilli, Claudia, Zingaretti, Chiara, Donati, Caterina, Masini, Carla, Monti, Manuela, Serra, Patrizia, Vespignani, Roberto, Grossi, Veruska, Biggeri, Annibale, Scarpi, Emanuela, Galardi, Francesca, Bertoni, Lucia, Colamartini, Americo, Falcini, Fabio, Altini, Mattia, Massa, Ilaria, Gaggeri, Raffaella, Martinelli, Giovanni
Publicado no Trials (2020)

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

Por Galardi, Francesca, De Luca, Francesca, Biagioni, Chiara, Migliaccio, Ilenia, Curigliano, Giuseppe, Minisini, Alessandro M., Bonechi, Martina, Moretti, Erica, Risi, Emanuela, McCartney, Amelia, Benelli, Matteo, Romagnoli, Dario, Cappadona, Silvia, Gabellini, Stefano, Guarducci, Cristina, Conti, Valerio, Biganzoli, Laura, Di Leo, Angelo, Malorni, Luca
Publicado no Breast Cancer Res (2021)